North Macedonia vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
North Macedonia
100.0%
in 2020
Sur
82.0%
in 2024
North Macedonia rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- North Macedonia
- Sur
How they compare
North Macedonia currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes North Macedonia's figure about 1.2 times Sur's.
Across all 6 years both countries report, North Macedonia has been ahead every year.
North Macedonia ranks 1st and Sur ranks 2nd of 144 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | North Macedonia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 21.0% | 79.0% | North Macedonia |
| 2010s | 100.0% | 82.0% | 18.0% | North Macedonia |
| 2020s | 100.0% | 77.0% | 23.0% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), North Macedonia or Sur?
- North Macedonia, at 100.0% against 82.0% in Sur as of 2020.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between North Macedonia and Sur?
- 18.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Sur?
- 6 years are reported by both, from 2005 to 2020.
- How do North Macedonia and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- North Macedonia ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.